Xometry Inc
For the period ended Mar 31, 2025. Filed May 6, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 6, 2025
XMTR$119.31-1.1%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets (Unaudited)
Balance Sheets
| March 31, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $15,507 | $22,232 |
| Marketable securities | 215,874 | 217,603 |
| Accounts receivable, less allowance for credit losses of $5.1 million and $4.9 million as of March 31, 2025 and December 31, 2024 | 85,529 | 73,962 |
| Inventory | 4,032 | 3,915 |
| Prepaid expenses | 6,487 | 4,954 |
| Other current assets | 7,189 | 4,874 |
| Total current assets | 334,618 | 327,540 |
| Property and equipment, net | 47,244 | 44,825 |
| Operating lease right-of-use assets | 7,231 | 8,462 |
| Investment in unconsolidated joint venture | 4,071 | 4,065 |
| Intangible assets, net | 31,244 | 32,139 |
| Goodwill | 263,009 | 262,686 |
| Other assets | 2,693 | 412 |
| Total assets | $690,110 | $680,129 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable and accrued cost of revenue | $50,218 | $35,023 |
| Other accrued expenses | 23,122 | 24,401 |
| Contract liabilities | 9,908 | 7,948 |
| Income taxes payable | 887 | 979 |
| Operating lease liabilities, current portion | 5,293 | 6,436 |
| Total current liabilities | 89,428 | 74,787 |
| Convertible notes | 284,093 | 283,628 |
| Operating lease liabilities, net of current portion | 4,523 | 5,072 |
| Deferred income taxes | 229 | 229 |
| Other liabilities | 804 | 817 |
| Total liabilities | 379,077 | 364,533 |
| Commitments and contingencies (Note 9) | ||
| Stockholders’ equity | ||
| Preferred stock, $0.000001 par value. Authorized; 50,000,000 shares; zero shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | — | — |
| Class A Common stock, $0.000001 par value. Authorized; 750,000,000 shares; 48,992,113 shares and 48,289,274 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively | — | — |
| Class B Common stock, $0.000001 par value. Authorized; 5,000,000 shares; 1,475,311 shares issued and outstanding as of March 31, 2025 and December 31, 2024 | — | — |
| Additional paid-in capital | 694,047 | 685,054 |
| Accumulated other comprehensive income (loss) | 1,205 | (328) |
| Accumulated deficit | (385,351) | (370,273) |
| Total stockholders’ equity | 309,901 | 314,453 |
| Noncontrolling interest | 1,132 | 1,143 |
| Total equity | 311,033 | 315,596 |
| Total liabilities and stockholders’ equity | $690,110 | $680,129 |
Condensed Consolidated St
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.